Global Veterinary Antimicrobial Susceptibility Testing Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Veterinary Antimicrobial Susceptibility Testing Market Analysis

The veterinary antimicrobial susceptibility testing market is witnessing significant growth, driven by the increasing prevalence of infectious diseases in both food-producing and companion animals, alongside heightened awareness regarding antibiotic resistance. As veterinarians and pet owners become more conscious of the need for effective and responsible antibiotic use, there is a growing demand for precise testing methods that can guide treatment decisions. Technological advancements, such as the development of automated testing instruments and rapid testing solutions, are enhancing the efficiency and accuracy of antimicrobial susceptibility testing. Furthermore, regulatory support and initiatives aimed at promoting responsible antibiotic use in veterinary medicine are bolstering market growth. With a diverse range of end-users, including veterinary reference laboratories, research institutes, and clinics, the market is expected to expand as more innovative testing solutions are introduced, addressing the critical need for effective management of infectious diseases in animals.

Veterinary Antimicrobial Susceptibility Testing Market Size

The global veterinary antimicrobial susceptibility testing market size was valued at USD 39.61 billion in 2023 and is projected to reach USD 59.60 billion by 2031, with a CAGR of 5.24% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Veterinary Antimicrobial Susceptibility Testing Market Trends

“Growing Emphasis on Antibiotic Stewardship”

O mercado veterinário de testes de susceptibilidade antimicrobiana está a registar um crescimento substancial devido às crescentes preocupações com a resistência aos antibióticos e à crescente incidência de doenças infeciosas em animais de companhia e produtores de alimentos. Uma tendência significativa no mercado é a crescente ênfase na administração de antibióticos, que incentiva o uso responsável de antibióticos nas práticas veterinárias. À medida que os veterinários se esforçam por otimizar os resultados do tratamento e, ao mesmo tempo, minimizar o risco de resistência, a procura por testes precisos de suscetibilidade antimicrobiana está a aumentar. Além disso, os avanços nas tecnologias de testes rápidos e de diagnóstico molecular estão a aumentar a velocidade e a precisão destes testes, impulsionando ainda mais o crescimento do mercado. No geral, o mercado veterinário de testes de susceptibilidade antimicrobiana está preparado para uma expansão contínua, à medida que as inovações nos métodos de teste e o foco na administração remodelam o panorama dos cuidados veterinários.

Âmbito do relatório e segmentação do mercado de testes de susceptibilidade antimicrobiana veterinária

Definição do mercado de testes de sensibilidade antimicrobiana veterinária

O Teste Veterinário de Suscetibilidade Antimicrobiana (VAST) refere-se a um procedimento laboratorial utilizado para determinar a eficácia dos agentes antimicrobianos contra bactérias ou agentes patogénicos específicos isolados de animais. Estes testes ajudam os médicos veterinários a identificar quais os antibióticos ou medicamentos antimicrobianos mais eficazes no tratamento de infeções em animais, garantindo escolhas de tratamento adequadas que podem melhorar a saúde animal e reduzir o risco de resistência aos antibióticos. A VAST desempenha um papel fundamental na medicina veterinária, particularmente na gestão de doenças infeciosas, orientando os protocolos de tratamento e promovendo o uso responsável de antimicrobianos na pecuária.

Dinâmica do mercado de testes de susceptibilidade antimicrobiana veterinária

Motoristas

• Crescente prevalência de resistência antimicrobiana

A crescente prevalência da resistência antimicrobiana (RAM) em animais é um motor de mercado crítico para o setor veterinário de testes de sensibilidade antimicrobiana (AST). A RAM representa uma séria ameaça à saúde e ao bem-estar dos animais e prejudica a eficácia dos tratamentos antimicrobianos, conduzindo a doenças prolongadas e ao aumento das taxas de mortalidade entre rebanhos e animais de companhia. Os testes veterinários de susceptibilidade aos antimicrobianos desempenham um papel vital neste contexto, identificando os agentes antimicrobianos mais eficazes para o tratamento de infecções, ajudando assim a combater o desafio da RAM. Ao utilizar a AST, os médicos veterinários podem adaptar planos de tratamento para garantir a seleção de antimicrobianos apropriados, melhorando os resultados do tratamento e minimizando o risco de desenvolvimento de resistência. Este crescente reconhecimento da importância da AST na gestão da RAM está a impulsionar a procura no sector veterinário, contribuindo assim significativamente para a expansão do mercado veterinário de testes de susceptibilidade antimicrobiana.

• Aumento da incidência de doenças infeciosas

A crescente incidência de doenças infeciosas entre animais de companhia e produtores de alimentos é um dos principais impulsionadores do mercado veterinário de testes de sensibilidade antimicrobiana. À medida que os surtos de infeções como o parvovírus canino e a leucemia felina se tornam mais comuns, os veterinários enfrentam o desafio de diagnosticar e tratar eficazmente estas doenças. Por exemplo, um relatório da Associação Médica Veterinária Americana indicou que houve um aumento notável de infecções bacterianas resistentes a antibióticos no gado, sendo necessária a utilização de testes precisos de susceptibilidade antimicrobiana para identificar opções de tratamento eficazes. Esta crescente prevalência de doenças infecciosas aumenta a procura de testes precisos e sublinha a importância de abordagens terapêuticas personalizadas na medicina veterinária. Como resultado, a urgência de gerir eficazmente estas doenças infeciosas está a impulsionar o mercado de soluções de testes de susceptibilidade antimicrobiana, reforçando a necessidade de ferramentas de diagnóstico avançadas nas práticas veterinárias.

Oportunidades

• Aumento da adoção de testes no local de atendimento

O teste no local de atendimento (POCT) envolve a realização de testes de diagnóstico e a obtenção de resultados em tempo real no local de atendimento ao paciente. A adoção do POCT na medicina veterinária está a aumentar, apresentando uma oportunidade significativa para o desenvolvimento de dispositivos portáteis e fáceis de utilizar para testes de suscetibilidade antimicrobiana que podem ser utilizados diretamente em clínicas veterinárias ou no terreno. Estas soluções de testes rápidos oferecem resultados imediatos, permitindo aos médicos veterinários tomar decisões de tratamento imediatas com base nos padrões específicos de resistência antimicrobiana dos agentes patogénicos envolvidos. Esta capacidade melhora a qualidade dos cuidados prestados aos animais e contribui para uma gestão mais eficaz da doença e para melhores resultados para os doentes. Ao facilitar intervenções atempadas, o POCT pode desempenhar um papel crucial na melhoria geral da saúde e do bem-estar animal.

• Alargamento dos Laboratórios de Referência Veterinária

Os laboratórios veterinários de referência são essenciais na prestação de serviços de diagnóstico especializados, particularmente testes de sensibilidade antimicrobiana, a clínicas veterinárias e hospitais. À medida que aumenta a procura por testes de diagnóstico precisos e abrangentes, estes laboratórios têm uma oportunidade significativa de expansão. Ao investir em tecnologias de testes avançadas, como sistemas automatizados e diagnóstico molecular, os laboratórios veterinários de referência podem aumentar a sua eficiência e precisão no diagnóstico de infeções. Além disso, a expansão das suas capacidades de testes permite-lhes acomodar um maior volume de amostras e oferecer uma gama mais ampla de serviços de testes de susceptibilidade antimicrobiana. Este crescimento estratégico ajuda a satisfazer a crescente procura do mercado e apoia os médicos veterinários na tomada de decisões de tratamento informadas, melhorando, em última análise, os resultados da saúde animal e promovendo a utilização responsável de antibióticos na medicina veterinária.

Restraints/Challenges

• High Costs of Antimicrobial Susceptibility Testing

The high costs associated with antimicrobial susceptibility testing represent a significant barrier for veterinary clinics, particularly in developing regions where budget constraints restrict access to advanced diagnostics. Many veterinary practices, especially smaller clinics, may find it challenging to invest in the necessary testing equipment and reagents, which can be prohibitively expensive. This financial hurdle can lead to a reliance on traditional treatment methods without the benefit of tailored antimicrobial therapy, potentially resulting in ineffective treatment outcomes and contributing to the rise of antimicrobial resistance. As a consequence, the lack of affordable testing options limits the overall adoption of antimicrobial susceptibility testing in veterinary medicine. This challenge hampers market growth, as the inability to conduct effective testing may undermine efforts to improve animal health and welfare.

• Stringent Regulatory Standards

The veterinary antimicrobial susceptibility testing market encounters significant regulatory hurdles that can impede the approval and commercialization of new diagnostic products. Stringent regulatory requirements often necessitate extensive clinical trials and comprehensive documentation to demonstrate the safety and efficacy of testing devices and procedures. These lengthy processes can delay the introduction of innovative solutions into the market, which is critical for addressing emerging challenges related to antimicrobial resistance in veterinary medicine. Furthermore, navigating the complex landscape of regulations across different countries can be daunting for companies, especially smaller firms lacking the resources to manage compliance effectively. As a result, these regulatory challenges can hinder the timely availability of advanced diagnostic tools, limiting the market's growth and reducing veterinarians' ability to implement effective antimicrobial stewardship practices.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Veterinary Antimicrobial Susceptibility Testing Market Scope

The market is segmented on the basis of product type, animal type, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Disks and Plates
• Culture Media
• Accessories and Consumables
• Automated Antimicrobial Susceptibility Testing Instruments

Animal Type

• Food-producing Animals
  • Cattle
  • Poultry
  • Pigs
  • Others (Sheep, Goats, Veal)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others (Birds, Fish, Turtles)

End User

• Veterinary Reference Laboratory
• Veterinary Research Institutes and Universities
• Others

Veterinary Antimicrobial Susceptibility Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, animal type, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global veterinary antimicrobial susceptibility testing market due to its robust and advanced healthcare infrastructure, particularly in veterinary care. The region is equipped with an extensive network of veterinary clinics, diagnostic laboratories, and research institutions, all of which possess the resources and expertise required to conduct antimicrobial susceptibility testing effectively.

Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, driven by its large and expanding population that is increasingly demanding animal protein, such as meat, milk, and eggs. The intensification of animal production systems and the higher density of livestock can lead to the spread of infectious diseases and antimicrobial resistance. Consequently, there is an escalating need for effective diagnostics, including antimicrobial susceptibility testing, to safeguard the health and productivity of livestock and aquaculture.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Veterinary Antimicrobial Susceptibility Testing Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Veterinary Antimicrobial Susceptibility Testing Market Leaders Operating in the Market Are:

• BD (U.S.)
• Synbiosis (U.S.)
• Zhuhai DL Biotech Co., Ltd. (China)
• Mast Group Ltd. (U.K.)
• HiMedia Laboratories (India)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Creative Diagnostics (U.S.)
• Genefluidics, Inc. (U.S.)
• ROSCO DIOGNISTICA (Germany)
• Erba Mannheim (U.S.)
• Liofilchem S.r.l. (Italy)
• Alifax S.r.l. (Italy)
• MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
• BIOMÉRIEUX (France)
• Merck KGaA (U.S.)
• Danaher (U.S.)
• Accelerate Diagnostics, Inc. (U.S.)
• NuMedii, Inc. (U.S.)

Latest Developments in Veterinary Antimicrobial Susceptibility Testing Market

• In June 2023, bioMérieux achieved a remarkable milestone by receiving nine IMV ServiceTrak clinical laboratory awards. These awards recognized the company’s excellence across several key segments, including Immunoassay, ID/AST, and Blood Culture, highlighting its commitment to delivering high-quality diagnostic solutions and reinforcing its leadership position in the clinical laboratory market
• In April 2023, Bio-Rad Laboratories, Inc. introduced the ID-Check Speciation Solution, a cutting-edge tool designed to determine the animal species origin of meat samples. This innovative solution is invaluable for food, feed, and environmental testing, ensuring accurate identification and enhancing food safety and traceability in the supply chain
• In October 2022, Bioguard Corporation achieved a significant milestone by receiving ISO 17025 accreditation for its animal health diagnostic center. This accreditation underscores the organization’s commitment to maintaining high standards in laboratory practices, ensuring that its diagnostic services meet international quality requirements and can be relied upon by veterinary professionals
• In August 2022, Becton, Dickinson and Company entered into a commercial collaboration agreement with Accelerate Diagnostics, Inc. This strategic partnership aims to enhance the distribution of Accelerate’s comprehensive portfolio of antibiotic resistance and susceptibility products, thereby improving access to advanced diagnostic tools that are crucial for effective infection management
• In June 2021, bioMérieux entered into a distribution agreement with Specific Diagnostics to distribute their REVEAL Rapid AST system across Europe. This partnership allows bioMérieux to expand its portfolio of antimicrobial susceptibility testing solutions, enhancing its ability to deliver rapid and accurate diagnostics to healthcare providers in the region

SKU-66356